GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference

116 calculators match

Most used

21
MELD-NaAssesses the severity of chronic liver diseaseChild-Pugh ScoreAssesses the prognosis of chronic liver disease, mainly cirrhosisFIB-4 IndexLiver fibrosis scoring indexAPRIAST to platelet ratio — liver fibrosisMaddrey's DFAlcoholic hepatitis severityGlasgow-BlatchfordUpper GI bleed risk stratificationGAHSGlasgow alcoholic hepatitis scoreMontreal IBDIBD classification — CD & UCMayo ScoreUlcerative colitis activityBISAP ScoreBedside index for severity of pancreatitisCLIF-SOFAOrgan failure scoring in cirrhosisAlcohol ContentStandard drinks & alcohol grams calculatorAARC-ACLFAcute-on-chronic liver failure gradePELD / CR ScorePediatric end-stage liver diseaseHarvey-BradshawCrohn's disease activity indexCTSICT severity index — pancreatitisRockall ScoreGI bleed rebleeding & mortality riskCAGEAlcohol use disorder screening (4 questions)MELD 3.0Updated MELD — sex-inclusive formulaAUDIT ScoreAlcohol use disorders identification testVOCAL-Penn ScorePost-operative mortality risk in cirrhosis surgery

Liver & Cirrhosis

17
ALBI GradeAlbumin-bilirubin liver function grade in HCCUKELD ScoreUK model for end-stage liver diseaseMELD-XIMELD excluding INR — for anticoagulated patientsWest Haven CriteriaHepatic encephalopathy gradingMilan CriteriaLiver transplant eligibility in hepatocellular carcinomaLI-RADS v2018 (CT/MRI)Liver observation category from size, APHE and major featuresBCLC StagingHepatocellular carcinoma stage and treatment allocationSimplified AIH CriteriaSimplified criteria for autoimmune hepatitisRevised Original AIH ScoreIAIHG 1999 comprehensive autoimmune hepatitis scoreSAAGSerum-ascites albumin gradient — cause of ascitesR FactorHepatocellular vs cholestatic pattern in liver injuryCLIF-C ACLFMortality prediction in acute-on-chronic liver failureKing's College CriteriaTransplant criteria in acute liver failureGALAD ScoreHCC detection from gender, age, AFP-L3, AFP and DCPMetroticket 2.0AFP-adjusted up-to-seven for HCC transplant eligibilityRUCAMCausality in drug- and herb-induced liver injuryBaveno VII CriteriacACLD, CSPH and sparing screening endoscopy

Fibrosis & MASLD

8
NAFLD Fibrosis ScoreAdvanced fibrosis probability in MASLD/NAFLDBARD ScoreBMI, AST/ALT ratio, diabetes — MASLD fibrosisFatty Liver IndexPredicts hepatic steatosis from routine labsFibrotic NASH Index (FNI)At-risk NASH probability from AST, HbA1c and HDLNAFLD Activity Score (NAS)Histologic activity grade — steatosis, inflammation, ballooningMEFIB IndexMRE + FIB-4 rule for significant fibrosis (≥F2) in MASLDFAST ScoreFibroScan-AST — at-risk NASH from LSM, CAP and ASTSAFE ScoreSteatosis-Associated Fibrosis Estimator for MASLD in primary care

Pancreas & Biliary

8
Ranson's CriteriaAcute pancreatitis severity at 48 hoursGlasgow-Imrie CriteriaAcute pancreatitis severity — the PANCREAS criteriaHAPSHarmless acute pancreatitis scoreTokyo Guidelines — CholangitisTG18 diagnosis and severity grade for acute cholangitisTokyo Guidelines — CholecystitisTG18 diagnosis and severity grade for acute cholecystitisBiliary Pain (Rome IV)Rome IV — defining biliary-type pain before interventionFunctional Pancreatic SODRome IV — pancreatic sphincter of Oddi disorderRevised Atlanta ClassificationAcute pancreatitis severity — mild, moderately severe, severe

IBD

9
Truelove & Witts CriteriaAcute severe ulcerative colitis — admission decisionUCEISUlcerative colitis endoscopic index of severitySCCAISimple clinical colitis activity index — symptoms onlyCDAICrohn's disease activity index — the trial standardSES-CDEndoscopic severity in Crohn's diseasePUCAIPaediatric ulcerative colitis activity indexTravis (Oxford) CriteriaDay 3 colectomy risk in acute severe ulcerative colitisHo IndexDay 3 steroid failure risk in acute severe ulcerative colitisRutgeerts ScorePostoperative Crohn's recurrence at ileocolonoscopy

GI Bleeding

7
EVendo ScorePredicts oesophageal varices needing treatmentForrest ClassificationPeptic ulcer bleeding — rebleeding risk at endoscopyAIMS65 ScoreUpper GI bleed mortality — five bedside criteriaOakland ScoreSafe-discharge risk for acute lower GI bleedingABC ScoreAge, blood tests, comorbidities — GI bleed mortalitySarin ClassificationEndoscopic classification of gastric varicesEGUS (Gastric Ulcer)Malignancy risk in a gastric ulcer, and who needs repeat endoscopy

Alcohol

2
ABIC ScoreAge, bilirubin, INR, creatinine — alcoholic hepatitisLille ModelSteroid response at day 7 in alcoholic hepatitis

Upper GI

4
Chicago Classification v4.0Oesophageal motility pattern from high-resolution manometryLA Classification (Oesophagitis)Los Angeles grade A–D for erosive oesophagitisPrague C & M CriteriaCircumferential and maximal extent of Barrett's oesophagusEREFS (Eosinophilic Oesophagitis)Endoscopic reference score — oedema, rings, exudates, furrows, stricture

Colorectal

3
Boston Bowel Prep ScaleColonoscopy preparation adequacy by segmentStool Osmotic GapOsmotic vs secretory diarrhoea from stool electrolytesATLAS Score (C. difficile)Predicted response to therapy in Clostridioides difficile infection

Functional GI

37
Bristol Stool ScaleStool form types 1–7 and colonic transitRome IV Criteria for IBSIrritable bowel syndrome diagnosis and subtypeFunctional ConstipationRome IV — two of six items, IBS excludedOpioid-Induced ConstipationRome IV — constipation tied to opioid therapyFunctional DiarrhoeaRome IV — loose stools without predominant painFunctional Bloating / DistensionRome IV — bloating without other bowel disorder criteriaUnspecified Functional Bowel DisorderRome IV — bowel symptoms fitting no other categoryCentrally Mediated Abdominal Pain (CAPS)Rome IV — continuous pain unrelated to gut eventsNarcotic Bowel SyndromeRome IV — opioid-induced hyperalgesia of the gutFaecal Incontinence (Rome IV)Rome IV — the criteria, and why nobody is askedFunctional Anorectal PainLevator ani, unspecified pain and proctalgia fugaxFunctional Defecation DisordersRome IV — dyssynergia and inadequate propulsionInfant RegurgitationRome IV — the happy spitter, and the alarm features that rule it outInfant ColicRome IV — recurrent unexplained crying in a well infant under 5 monthsInfant DyscheziaRome IV — straining before a soft stool, and why not to intervenePaediatric Functional ConstipationRome IV — two of six over one month, with overflow soiling as a criterionToddler's DiarrhoeaRome IV functional diarrhoea of childhood — painless, thriving childPaediatric Cyclic Vomiting SyndromeRome IV — both age bands, with different criteria for eachPaediatric Rumination SyndromeRome IV — infant and child/adolescent criteriaFunctional Nausea & Vomiting (Children)Rome IV — two separate disorders that can be met togetherAerophagiaRome IV — distension that increases through the dayPaediatric Functional DyspepsiaRome IV — four times a month, with PDS and EPS subtypingPaediatric Irritable Bowel SyndromeRome IV — plus the constipation clause clinicians missAbdominal MigraineRome IV — stereotypical incapacitating episodes weeks apartFunctional Abdominal Pain — NOSRome IV — the residual category, reached after the other threeNonretentive Faecal IncontinenceRome IV — soiling without retention, where laxatives make it worseFunctional DyspepsiaRome IV — with PDS and EPS subtypingRumination SyndromeRome IV — effortless regurgitation without retchingCyclic Vomiting SyndromeRome IV — stereotypical episodic vomitingCannabinoid HyperemesisRome IV — CVS pattern relieved by cannabis cessationChronic Nausea & VomitingRome IV — chronic nausea and vomiting syndromeBelching DisordersRome IV — supragastric vs gastric belchingFunctional HeartburnRome IV — heartburn with normal acid exposureReflux HypersensitivityRome IV — normal acid exposure, positive symptom associationFunctional Chest PainRome IV — non-cardiac, non-reflux chest painGlobusRome IV — painless lump-in-throat sensationFunctional DysphagiaRome IV — dysphagia with normal endoscopy and manometry
  1. Calculators
  2. /
  3. Cyclic Vomiting Syndrome
Functional GI

Cyclic Vomiting Syndrome

Rome IV — stereotypical episodic vomiting

Stereotypical means the episodes resemble each other closely — same onset, same character, same duration. That consistency is the diagnostic hallmark.

Both counts are required, not either. The 1-week separation prevents a single prolonged illness being counted as multiple episodes.

Vomiting between episodes points to chronic nausea and vomiting syndrome instead. Milder interepisodic symptoms such as nausea are permitted and are common in adults.

The pattern is what defines it: stereotypical acute episodes lasting under a week, with a specific episode count, and complete absence of vomiting between them.

When to use
Use it in a patient with recurrent discrete attacks of vomiting separated by genuinely well periods. The criteria are most valuable for the two things clinicians tend not to pin down: whether the episodes really are stereotypical, and whether the counts are met — a patient with two episodes in five years does not have this disorder, however severe those episodes were. Before settling on it, ask about cannabis, because cannabinoid hyperemesis syndrome produces an identical pattern and is distinguished only by exposure and by response to cessation. It does not apply where vomiting continues between attacks, which describes chronic nausea and vomiting syndrome instead.
Why use it
Because these patients present acutely, repeatedly, to people who have not seen them before, and the pattern that makes the diagnosis is invisible from inside a single episode. Each attack looks like an acute abdomen or an intractable emesis of unknown cause, and gets investigated as one; the diagnosis only becomes apparent when someone looks across attacks and notices that they are all the same. Rome IV's episode counts force that longitudinal view. Making the diagnosis matters because management is genuinely two-phase — abortive therapy during an attack and prophylaxis between them — and prophylaxis is never reached if every episode is treated as a fresh event.
Formula, evidence and interpretation

About the Rome IV Criteria for Cyclic Vomiting Syndrome

What defines cyclic vomiting syndrome is the shape of the illness over time, not the severity of any one attack. Rome IV requires stereotypical episodes of vomiting as to onset (acute) and duration (less than one week); at least three discrete episodes in the prior year *and* two in the past six months, occurring at least a week apart; and absence of vomiting between episodes, though milder interepisodic symptoms are permitted. Criteria are fulfilled over three months with onset at least six months ago. A personal or family history of migraine is a supportive remark, and it points toward the prophylaxis that works.

On this page

  • Formula
  • Interpreting the result
  • Inputs
  • What it returns
  • How it is calculated
  • Facts & figures
  • Evidence
  • How it compares
  • Pearls & pitfalls
  • Critical actions
  • Why it exists
  • About the creator
  • Limitations
  • If you are the patient
  • FAQ
  • Related calculators
  • References

Formula

Cyclic vomiting syndrome = ALL of: stereotypical episodes of vomiting, acute in onset and lasting under 1 week AND at least 3 discrete episodes in the prior year and 2 episodes in the past 6 months, at least 1 week apart AND absence of vomiting between episodes (milder interepisodic symptoms are permitted) AND criteria fulfilled for the last 3 months, onset at least 6 months ago Supportive: personal or family history of migraine headaches
Stereotypical
The same episode each time in onset, duration and symptoms. Variability argues against the diagnosis and towards a structural or metabolic cause.
3 in a year and 2 in 6 months
Rome IV states both counts explicitly, and requires episodes at least a week apart.
Absence of vomiting between episodes
Milder interepisodic symptoms are permitted; vomiting between episodes is not, and points to chronic nausea and vomiting instead.
  • Rome IV specifies the episode counts explicitly and allows milder symptoms between episodes, which the paediatric-derived definition did not.
  • A migraine history is supportive rather than required.

Interpreting the result

Meeting the criteria should immediately prompt two things. First, ask about cannabis in detail, because cannabinoid hyperemesis syndrome is defined by Rome IV as resembling this disorder and cannot be separated from it on the episodes alone — and it is far more common now than when these criteria were written. Second, split management into abortive and prophylactic. Abortive therapy during an attack includes triptans, anti-emetics and fluids, and works better the earlier it is given, which is an argument for a written plan the patient carries. Prophylaxis between attacks — commonly amitriptyline or topiramate — is what reduces episode frequency, and it is the half most often never started because each presentation is handled acutely and the patient is discharged. Ask about migraine, personally and in the family, since it supports the diagnosis and predicts response to prophylaxis. Where criteria are not met, check which one failed: interepisodic vomiting points to chronic nausea and vomiting syndrome, while unmet counts may simply mean the pattern has not yet declared itself and warrant review rather than exclusion.

ScoreBandWhat it meansAction
All criteria metCyclic vomiting syndromeStereotypical acute episodes under a week, meeting the episode counts, with well periods in betweenAsk about cannabis; start abortive therapy planning and prophylaxis. Ask about migraine, personal and family
Vomiting between episodesCriteria not met — continuous patternVomiting between attacks is incompatible with the cyclic patternAssess for chronic nausea and vomiting syndrome instead
Episode counts unmetCriteria not met — pattern not yet establishedFewer than three episodes in the prior year or two in the past six monthsReview rather than exclude; the pattern may declare itself with time. Keep an episode diary

What the Cyclic Vomiting Syndrome needs (4 inputs)

Timing
Criteria fulfilled for the last three months with symptom onset at least six months before diagnosis.
Stereotypical episodes of vomiting as to onset (acute) and duration (less than 1 week)
Stereotypical is the operative word: the episodes resemble one another closely in how they start, how they feel and how long they last. That consistency is the diagnostic hallmark and is what distinguishes this from recurrent vomiting of varied cause.
At least three discrete episodes in the prior year AND two in the past 6 months, at least 1 week apart
Both counts are required, not either. The one-week separation exists to stop a single prolonged illness with fluctuation being counted as several episodes.
Absence of vomiting between episodes (milder interepisodic symptoms permitted)
Vomiting between attacks moves the diagnosis to chronic nausea and vomiting syndrome. Milder symptoms such as background nausea are explicitly allowed, and are common in adults — Rome IV notes this as a difference from the paediatric presentation.

What it returns

Criteria met or not met
All four requirements including the timing rule must hold simultaneously.
Which criteria remain outstanding
Named explicitly. Failure is most often on the episode counts or on interepisodic vomiting, and the two have different implications.

How it is calculated

The criteria are built entirely on pattern recognition across time, which is unusual among the Rome definitions and reflects what the disorder actually is. There is no biomarker, no characteristic finding during an attack, and nothing about the vomiting itself that differs from vomiting of any other cause. What differs is the architecture: acute onset, self-limiting duration under a week, close resemblance between attacks, and complete or near-complete wellness in between. The episode counts turn that observation into something checkable. The mechanistic account links the disorder to migraine — shared triggers, a shared response to migraine prophylaxis, and a high rate of personal and family migraine history — which is why Rome IV lists migraine as a supportive remark and why the treatment borrows directly from migraine practice.

Facts & figures

The three ways this can fail, and what each one means
Unmet criterionWhat it points to
Vomiting between episodesChronic nausea and vomiting syndrome — a continuous rather than cyclic disorder
Episodes not stereotypicalRecurrent vomiting of varied cause; look for a different explanation for each attack
Episode counts not reachedPossibly early in the course — review rather than exclude, and keep a diary
Episodes lasting over a weekFalls outside the definition; reconsider obstruction, metabolic and central causes

Failing on the counts is not the same as failing on the pattern. A patient with two identical episodes six months apart may simply be early, and should be reviewed rather than told they do not have the disorder.

Two-phase management
PhaseApproach
Abortive — during an attackTriptans, anti-emetics, fluids and electrolyte correction. Works better the earlier it is given, which favours a written plan the patient carries
Prophylactic — between attacksCommonly amitriptyline or topiramate; reduces episode frequency and is the half most often never started
Trigger managementStress, sleep deprivation and menstruation are the usual identifiable triggers

Because each attack presents acutely and is managed acutely, prophylaxis is frequently never initiated. That gap is the main reason the diagnosis is worth making explicitly rather than treating each episode on its own terms.

Evidence

Derivation — Rome Foundation, gastroduodenal disorders committee

2016

Consensus criteria from the Rome IV gastroduodenal disorders committee, published in Gastroenterology in 2016.

Consensus-derived. Rome IV specified the episode counts explicitly — at least three in the prior year and two in the past six months — and added the allowance for milder interepisodic symptoms, which reflects that adult presentations differ from the paediatric pattern the disorder was first described in.

Management guidance — ANMS and CVSA 2019

2019

Guidelines on the management of cyclic vomiting syndrome in adults from the American Neurogastroenterology and Motility Society and the Cyclic Vomiting Syndrome Association.

Set out the two-phase approach of abortive and prophylactic therapy, endorse migraine-directed prophylaxis, and recommend assessing cannabis use in every patient presenting with this pattern.

How it compares

Cyclic Vomiting Syndrome vs Cannabinoid hyperemesis syndrome

Indistinguishable on the episodes — Rome IV defines cannabinoid hyperemesis in terms of this disorder, and only cannabis exposure and response to cessation separate them.

Any patient meeting cyclic vomiting criteria should be asked about cannabis before the label is settled. The two disorders share onset, duration, frequency and character of episodes; what differs is a prolonged habitual cannabis history, the compulsive hot bathing many patients with cannabinoid hyperemesis adopt, and above all resolution on sustained abstinence. The consequence of getting it wrong is substantial, because cannabinoid hyperemesis responds to cessation and not to migraine-directed prophylaxis, while cyclic vomiting syndrome responds to prophylaxis and not to anything about cannabis.

Open the Cannabinoid hyperemesis syndrome calculator →Venkatesan T, Levinthal DJ, Tarbell SE, et al. Guidelines on management of cyclic vomiting syndrome in adults by the American Neurogastroenterology and Motility Society and the Cyclic Vomiting Syndrome Association. Neurogastroenterol Motil. 2019;31 Suppl 2:e13604.

Cyclic Vomiting Syndrome vs Chronic nausea and vomiting syndrome

Separated by pattern, not severity — cyclic vomiting has discrete episodes with well periods, while chronic nausea and vomiting syndrome is continuous.

The discriminating question is what happens between attacks. Cyclic vomiting syndrome requires the absence of vomiting between episodes, though milder symptoms such as background nausea are allowed; chronic nausea and vomiting syndrome is defined by bothersome nausea at least one day a week or weekly vomiting without an episodic structure. Both can be severe, and severity does not distinguish them. The distinction matters because the two-phase abortive-and-prophylactic approach that works in cyclic vomiting syndrome does not map onto a continuous disorder.

Open the Chronic nausea and vomiting syndrome calculator →

Cyclic Vomiting Syndrome vs Rumination syndrome

Different mechanism entirely — rumination is effortless post-prandial regurgitation without retching, not episodic vomiting.

Patients frequently describe rumination as vomiting, which is why Rome IV requires it to be excluded before diagnosing the nausea and vomiting disorders. The separating question is whether retching precedes the event: in rumination it does not, and the material is recognisable food brought up within minutes of eating rather than gastric contents expelled during an acute attack. The distinction is worth making explicitly because rumination responds to diaphragmatic breathing and to nothing in the cyclic vomiting armamentarium.

Open the Rumination syndrome calculator →

Pearls & pitfalls

  • Ask about cannabis in every patient meeting these criteria. Cannabinoid hyperemesis syndrome is defined by Rome IV as resembling this disorder and cannot be separated on the episodes alone.
  • Both episode counts are required — three in the prior year AND two in the past six months. Meeting one and not the other does not satisfy the criterion.
  • The one-week separation matters. It prevents a single prolonged fluctuating illness being counted as multiple discrete episodes.
  • Milder symptoms between cycles are permitted and are common in adults. Excluding a patient because they have background nausea misapplies the criteria.
  • Vomiting between episodes is different and does exclude the diagnosis — that pattern is chronic nausea and vomiting syndrome.
  • Ask about migraine, personal and family. It is a supportive remark rather than a requirement, but it predicts response to prophylaxis.
  • Prophylaxis is the half of management most often never started, because each attack is handled acutely and the patient discharged. Make the plan between episodes, not during them.
  • Abortive therapy works better given early, so patients benefit from a written plan they carry rather than starting again at each presentation.
  • Failing the counts is not the same as failing the pattern. A patient early in their course should be reviewed with a diary rather than told they do not have the disorder.

Critical actions

  • Take a detailed cannabis history — frequency, duration and recent change — before settling on this diagnosis.
  • Establish that episodes are genuinely stereotypical and count them against both thresholds explicitly.
  • Ask about vomiting between attacks, since its presence moves the diagnosis elsewhere.
  • Ask about migraine in the patient and the family.
  • Exclude structural, metabolic and central causes appropriate to the presentation, particularly at first diagnosis.
  • Write an abortive plan the patient carries, so treatment starts early in the next attack rather than at presentation.
  • Start prophylaxis between episodes — this is the intervention that reduces frequency and the one most often omitted.
  • Identify triggers where possible: stress, sleep deprivation and menstruation are the usual ones.
  • Correct fluid and electrolyte disturbance during attacks, which can be substantial.

Why this score exists

The addition of explicit episode counts is the practical heart of the Rome IV revision. Cyclic vomiting syndrome had been recognised for over a century — first in children — but its adult definition had been loose enough that it was applied to almost any recurrent vomiting, which made both diagnosis and research unreliable. Requiring three episodes in a year and two in six months, at least a week apart, converts a clinical impression into something two clinicians can check the same way. The allowance for milder symptoms between cycles was the other significant change and came from adult data: the paediatric description of complete wellness between attacks turned out not to hold in adults, many of whom have background nausea, and the earlier wording was excluding patients who plainly had the disorder.

About the creator

  • Vincenzo Stanghellini

    First author, Rome IV gastroduodenal disorders committee

    Chaired the committee that produced the Rome IV gastroduodenal criteria.

  • William L. Hasler

    Co-author; nausea and vomiting disorders

    Co-authored the nausea and vomiting disorders section of the Rome IV gastroduodenal chapter.

  • Thangam Venkatesan

    First author, ANMS/CVSA adult management guidelines

    Led the adult management guidelines that translate these criteria into the abortive and prophylactic treatment framework.

Limitations

  • Entirely pattern-based with no biomarker, so the diagnosis depends on an accurate longitudinal history that is often not available at an acute presentation.
  • Cannot be distinguished from cannabinoid hyperemesis syndrome on the episodes themselves, so misclassification is inevitable in cannabis users.
  • The episode counts are consensus judgements rather than empirically derived thresholds, and exclude patients early in their course.
  • 'Stereotypical' requires a subjective judgement of similarity between attacks, which is difficult when episodes are reported retrospectively.
  • The allowance for milder interepisodic symptoms blurs the boundary with chronic nausea and vomiting syndrome.
  • The episode counts were set by agreement, not fitted to data, so nothing establishes that three episodes a year is the right boundary rather than two or four.
  • Says nothing about severity, and episodes range from manageable at home to requiring admission for dehydration and electrolyte disturbance.
  • Provides no guidance on the extent of investigation required at first presentation, which in practice varies widely.

If you are the patient

Cyclic vomiting syndrome means repeated attacks of severe vomiting that come on suddenly, last anywhere from hours to a few days, and then stop — with periods in between where you are well or nearly well. The attacks tend to be very similar to each other each time, which is one of the main clues doctors look for. To meet the formal definition you need at least three attacks in the past year and two in the past six months, at least a week apart. Two things are worth knowing. First, your doctor should ask about cannabis use, because heavy long-term cannabis use causes an almost identical pattern, and if that is the cause then stopping is the treatment — so it is important to answer honestly, and it is asked of everyone, not because of any assumption about you. Second, there are two separate parts to treatment, and people often only get one. There is treatment for an attack, which works better the earlier it is started — so it is worth having a written plan you carry so you are not starting from scratch each time. And there is preventive treatment taken between attacks to make them less frequent, which is the part that often gets missed because each attack is dealt with as an emergency and then everyone moves on. Ask about it specifically. Many people with this condition also get migraines, or have family members who do, and the preventive medicines used are often the same.

Frequently asked questions

What are the Rome IV criteria for cyclic vomiting syndrome?#

Stereotypical episodes of vomiting as to onset (acute) and duration (less than one week); at least three discrete episodes in the prior year and two episodes in the past six months, occurring at least one week apart; and absence of vomiting between episodes, though milder symptoms may be present between cycles. Criteria must be fulfilled for three months with onset at least six months earlier.

How many episodes are needed to diagnose cyclic vomiting syndrome?#

Both counts must be met: at least three discrete episodes in the prior year AND at least two in the past six months, separated by at least a week. Meeting one and not the other does not satisfy the criterion. The one-week separation prevents a single prolonged fluctuating illness being counted as several episodes.

Can you have symptoms between attacks?#

Milder symptoms such as background nausea are explicitly permitted, and are common in adults — Rome IV added this allowance because the paediatric description of complete wellness between attacks did not hold in adult patients. Vomiting between episodes is different and does exclude the diagnosis, pointing instead to chronic nausea and vomiting syndrome.

How is cyclic vomiting syndrome different from cannabinoid hyperemesis?#

Not by the episodes. Rome IV defines cannabinoid hyperemesis syndrome as resembling cyclic vomiting syndrome in onset, duration and frequency, so they cannot be separated on the attacks themselves. The differences are prolonged habitual cannabis use, the compulsive hot bathing many patients with cannabinoid hyperemesis adopt, and resolution on sustained cessation. Every patient meeting these criteria should be asked about cannabis.

Is cyclic vomiting syndrome related to migraine?#

Closely. A personal or family history of migraine is listed in Rome IV as a supportive remark, the disorders share triggers such as stress and sleep deprivation, and the prophylactic drugs that work — amitriptyline and topiramate — come directly from migraine practice. The relationship is strong enough that asking about migraine is a routine part of the assessment and predicts response to prophylaxis.

How is cyclic vomiting syndrome treated?#

In two phases. Abortive therapy during an attack — triptans, anti-emetics, fluids — which works better the earlier it is given, so a written plan the patient carries is valuable. And prophylaxis between attacks, commonly amitriptyline or topiramate, which reduces episode frequency. The prophylactic half is the one most often never started, because each attack is managed acutely and the patient discharged.

What if a patient has had fewer episodes than the criteria require?#

Review rather than exclude. Failing the episode counts is not the same as failing the pattern — a patient with two identical stereotypical episodes may simply be early in their course. Keeping an episode diary and reassessing is more useful than recording that the criteria are not met, particularly since the diagnosis rests entirely on a pattern that takes time to declare itself.

How long do cyclic vomiting episodes last?#

Less than a week, by definition — that upper bound is part of the criteria. Episodes lasting longer fall outside the definition and should prompt reconsideration of obstruction, metabolic and central causes rather than being absorbed into the diagnosis.

Related calculators

  • Cannabinoid Hyperemesis — Rome IV — CVS pattern relieved by cannabis cessation
  • Chronic Nausea & Vomiting — Rome IV — chronic nausea and vomiting syndrome
  • Rumination Syndrome — Rome IV — effortless regurgitation without retching
  • Functional Dyspepsia — Rome IV — with PDS and EPS subtyping
  • Belching Disorders — Rome IV — supragastric vs gastric belching

References

Original / primary reference

  1. Stanghellini V, Chan FKL, Hasler WL, Malagelada JR, Suzuki H, Tack J, Talley NJ. Gastroduodenal Disorders. Gastroenterology. 2016;150(6):1380-1392 (Rome IV).

Clinical practice guidelines

  1. Venkatesan T, Levinthal DJ, Tarbell SE, et al. Guidelines on management of cyclic vomiting syndrome in adults by the American Neurogastroenterology and Motility Society and the Cyclic Vomiting Syndrome Association. Neurogastroenterol Motil. 2019;31 Suppl 2:e13604.

Pathophysiology

  1. Levinthal DJ, Bielefeldt K. Cyclic vomiting syndrome: pathophysiology, comorbidities, and future research directions. Neurogastroenterol Motil. 2019;31 Suppl 2:e13607.

Last updated July 31, 2026. Clinical knowledge base written and curated by GastroAGI Team from primary medical literature.

Written from primary literature and not yet independently clinically reviewed.

For use by qualified healthcare professionals. This calculator supports clinical judgement and does not replace it.